Mass Spectrometry & Spectroscopy

  • Accelerate Adoption of Next-generation MS for Clinical Research, Forensic Toxicology and Clinical Trials

Accelerate Adoption of Next-generation MS for Clinical Research, Forensic Toxicology and Clinical Trials

Feb 15 2012 Read 1266 Times

AB Sciex and Indigo BioSystems recently announced an agreement to jointly market mass spectrometry solutions that streamline data acquisition and automate data review to ensure high quality results in clinical research and forensic toxicology as well as pre-clinical and clinical trials of new drugs. These joint solutions are expected to simplify and accelerate the use of new-generation mass spectrometry technologies. Under the terms of the agreement, AB Sciex is combining its industry-leading mass spectrometry platforms with Indigo BioSystems’s expert system software ASCENT™ with new-generation algorithms to simplify the use of mass spectrometry for those who are accustomed to using easy-to-use lab analysers. ASCENT™ adds value by automating the processing and review of data generated on AB Sciex mass spectrometry systems, which deliver the most accurate data possible with identification, quantitation and confirmation uniquely rolled up in a single workflow.

“Automation is an important step to accelerate the adoption of new-generation mass spectrometry for clinical research, forensics and clinical trials,” said Joe Anacleto, Vice President of Applied Markets and Clinical Research, AB Sciex. “We are striving to make mass spectrometry as easy to use as possible for researchers analysing steroids, pain panels, drugs of abuse and an expanding variety of substances. Our relationship with Indigo BioSystems allows us to bring LC/MS/MS solutions to researchers who may not ordinarily consider mass spectrometry but can now have the assurance of a simplified workflow while getting all the attractive benefits of LC/MS/MS technology.” LC/MS/MS, which is a versatile, proven analytical technology, provides significant benefits over alternative technologies, such as GC/MS (gas chromatography/mass spectrometry). LC/MS/MS represents the new frontier of mass spectrometry,  delivering the most accurate results, reduced sample preparation, lower cost per sample, and integrated qualitative and quantitative analysis. The combination of AB SCIEX’s and Indigo’s technologies will ensure the accuracy of  results, speed up batch release and increase compliance with QC rules needed to ensure high quality. “By embedding the knowledge of assay experts into the analysis software, we provide the foundation for smarter research laboratories,” said Indigo CEO Raul Zavaleta. “We are pleased to be partnering with the industry leader in LC/MS/MS to achieve this goal.”

Reader comments

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.

Post a Comment




Digital Edition

International Labmate July 2019

July 2019

In This Edition Mass Spectrometry & Spectroscopy - 67th ASMS Conference on Mass Spectrometry and Allied Topics - Modular MS Bench System with Integrated Gas Supply for Sciex LC-MS/MS Unveile...

View all digital editions

Events

AACC Annual Meeting & Clinical Lab Expo

Aug 04 2019 Anaheim, CA, USA

M&M 2019

Aug 04 2019 Portland, OR, USA

DXC 2019

Aug 05 2019 Lombard, IL, USA

ACS National Meeting & Expo, Fall 2019

Aug 25 2019 San Diego, CA, USA

Microscopy Conference 2019

Sep 01 2019 Berlin, Germany

View all events